Multiple somatic PTPN14 mutations have been associated with breast cancer, colon cancer and skin basal cell carcinoma suggesting an additional tumour suppressive role in preventing over-activation of the Hippo pathway in these cancer types [227–229]. The gene discussed is PTPN14; the disease is breast cancer.